Hawaii Biotech
Biotechnology, 650 Iwilei Rd Ste 204, Honolulu, Hawaii, 96817, United States, 11-50 Employees
Phone Number: 80********
Who is HAWAII BIOTECH
Hawaii Biotech, Inc. (HBI) is a privately held biotechnology company focused on the research and development of vaccines for established and emerging infectious diseases. The company has ...
Read More
-
Headquarters: 650 Iwilei Rd Ste 204, Honolulu, Hawaii, 96817, United States
-
Date Founded: 1982
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8731
|
NAICS Code: 541715 |
Show More
Does something look wrong? Fix it. | View contact records from HAWAII BIOTECH
Hawaii Biotech Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Hawaii Biotech
Answer: Hawaii Biotech's headquarters are located at 650 Iwilei Rd Ste 204, Honolulu, Hawaii, 96817, United States
Answer: Hawaii Biotech's phone number is 80********
Answer: Hawaii Biotech's official website is https://hibiotech.com
Answer: Hawaii Biotech's revenue is $10 Million to $25 Million
Answer: Hawaii Biotech's SIC: 8731
Answer: Hawaii Biotech's NAICS: 541715
Answer: Hawaii Biotech has 11-50 employees
Answer: Hawaii Biotech is in Biotechnology
Answer: Hawaii Biotech contact info: Phone number: 80******** Website: https://hibiotech.com
Answer: Hawaii Biotech, Inc. (HBI) is a privately held biotechnology company focused on the research and development of vaccines for established and emerging infectious diseases. The company has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. Current vaccine candidates in clinical or pre-clinical development target the West Nile virus, Tick borne flaviviruses, Zika virus, Crimean-Congo hemorrhagic fever virus, and Chikungunya virus. HBIs drug development activities are focused on small molecule drugs that block intracellular and extracellural bacterial toxins. Product opportunities include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company also partners its proprietary saponin adjuvant for vaccine development.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month